Transcatheter valve-in-valve for failing bioprosthetic aortic valve: Usually a good idea

Research output: Contribution to journalEditorial

Abstract

Use of bioprosthetic implants for surgical aortic valve replacements (SAVR) has been increasing in the recent years Surgical redo AVRs for failed surgical aortic bioprostheses have been traditionally considered the standard practice; however, in patients with higher surgical risk scores, transcatheter valve-in-valve aortic valve replacements are being commonly performed There is scarcity of data comparing these two approaches in this complex patient cohort Available data suggest that transcatheter ViV aortic valve replacement is generally a safe approach once some caveats are accounted for.

Original languageEnglish
Pages (from-to)1412-1413
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume92
Issue number7
DOIs
StatePublished - 1 Dec 2018

Fingerprint

Dive into the research topics of 'Transcatheter valve-in-valve for failing bioprosthetic aortic valve: Usually a good idea'. Together they form a unique fingerprint.

Cite this